Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 25,421 | 210,782 | 129,013 | 0 | 0 |
| Gross Profit | 25,421 | 210,782 | 129,013 | N/A | N/A |
| Operating Expenses | 183,319 | 163,771 | 132,175 | 97,248 | 51,127 |
| Operating Income | -157,898 | 47,011 | -3,162 | -97,248 | -51,127 |
| Other Income | 15,072 | 19,474 | 15,218 | 2,632 | -31 |
| Pre-tax Income | -142,826 | 66,485 | 12,056 | -94,616 | -51,158 |
| Income Tax | 924 | 859 | 18,741 | N/A | N/A |
| Net Income Continuous | -143,750 | 65,626 | -6,685 | -94,616 | -51,158 |
| Net Income | $-143,750 | $65,626 | $-6,685 | $-94,616 | $-51,158 |
| EPS Basic Total Ops | -3.47 | 1.76 | -0.20 | -3.02 | -8.16 |
| EPS Basic Continuous Ops | -3.47 | 1.76 | -0.20 | -3.02 | -8.16 |
| EPS Diluted Total Ops | -3.47 | 1.68 | -0.20 | -3.02 | -8.16 |
| EPS Diluted Continuous Ops | -3.47 | 1.68 | -0.20 | -3.02 | -8.16 |
| EPS Diluted Before Non-Recurring Items | -3.47 | 1.68 | -0.20 | -3.02 | -8.16 |
| EBITDA(a) | $-157,473 | $40,766 | $-6,100 | $-95,202 | $-50,010 |